Testing effectiveness (Phase 2)Study completedNCT00621894
What this trial is testing
Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation
Who this might be right for
Immune Thrombocytopenic Purpura
GlaxoSmithKline 23